Shares of CVS Health CVS fell 0.4% in pre-market trading after the company reported Q4 results.
Quarterly Results
Earnings per share fell 24.86% year over year to $1.30, which beat the estimate of $1.24.
Revenue of $69,554,000,000 higher by 3.98% from the same period last year, which beat the estimate of $68,750,000,000.
Guidance
The upcoming fiscal year's EPS expected to be between $7.39 and $7.55.
Revenue guidance hasn't been issued by the company for now.
Details Of The Call
Date: Feb 16, 2021
Time: 08:00 AM
Price Action
Company's 52-week high was at $77.23
Company's 52-week low was at $52.04
Price action over last quarter: Up 9.60%
Company Description
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing about 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with over 23 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.